Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Cybersecurity
Cybersecurity Vulnerabilities Need Addressing
Strengthen cyber defenses by guiding organizational behavior and reducing tactical errors.
By
Craig Callé
| May 17, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
cancer
M&A
Illumina Buys Cancer Test Startup Grail for $8B
The deal will move Illumina “deeper into the application of its gene-sequencing technology to the diagnosis and treatment of patients."
By
Matthew Heller
| September 21, 2020
Read More
Technology
J&J Buys Auris for $3B in Surgical Robotics Play
The deal is J&J's biggest move into surgical robotics, which "has been a gap for its medical device business."
By
Matthew Heller
| February 13, 2019
Read More
Risk & Compliance
Monsanto Cancer Verdict Rattles Bayer Shares
Analysts warn Bayer could face a "litigious headache" after the $289 million jury award in a product liability case over Monsanto's Roundup pesticide.
By
Matthew Heller
| August 14, 2018
Read More